Yesterday, our Elite Opportunity Pronewsletter suggested the ProShares UltraShort Nasdaq Biotech (NASDAQ: BIS) and Direxion Daily S&P Biotech Bear 3X Shares (NYSEARCA: LABD) as ways to short biotech onshort termweakness in the sector, but our suggestion comes with a long termcaveat:
We’ve done well with our individual small biotech plays over the last several months. However, depending on your timeframes and strategies, it appears the near-term could offer a bearish opportunity in the sector, while the longer-term may provide a bit more upside aheadHowever, I’ve said on a number of occasions lately, when these leveraged ETF’s take out new short-term highs or lows, they usually offer a pretty quick contrarian opportunity back in the other direction. And, with BIS now hovering right around a new short-term low, there could be an opportunity to short biotech as soon as today or tomorrow via getting long BIS.
- [By Jim Robertson]
Shares of small cap natural compound and Cannabinoid extract stock Radient Technologies (CVE: RTI) have been taking off lately as the Company makes further progress commercializing its technology. The Company extracts natural compounds from a range of biological materials using microwave assisted processing (MAP), a patented technology platform which provides superior customer outcomes in terms of ingredient purity, yield and cost. This technology is based on the selective and localized heating of the moisture present in all natural materials using microwaves as the energy source. This gives the Company a technological advantage and expertise in selectively depositing microwave energy into different parts of a biomass’ complicated chemical system form the core of our extraction advantage.
- [By Matthew Briar]
There’s an old business adage…. it’s not so much what you know, but who you know. If that’ s truly the case (and it is), then shareholders in Radient Technologies Inc (CVE:RTI) should be elated. The newest member of the Board of Directors that not already knows a lot of the right people, but has pretty much done all of things Radient would like to accomplish in the near future. That is, he was on the board for another ingredient and chemical company that was eventually acquired, but he also holds a masters degree in engineering. He can do it all, understanding the art and science of the business.
It’s yet another reason for RTI investors to be enthused.
Radient Technologies isn’t exactly a new company, but it’s relative notoriety is a fairly new phenomenon.
The organization, in simplest terms, has developed an ingredient-extraction process called microwave assisted processing, or “MAP,” for short. As the name implies, the use of radio microwaves helps the extraction process along.
Using its patented MAP process, Radient is able to selectively deposit microwave energy into a biomass (source material) and heat the target elements while leaving other materials in the mix unaltered. The near-instantaneous “in-core” heating that occurs creates pressure which drives out the targeting ingredient or component much faster than more conventional extraction methods. In fact, the pressure-driven process outperforms the conventional extraction on pretty much every front. That is, the technique reduces the extraction time from hours to minutes, delivers a higher active ingredient purity, increases the recovery of actives from often scarce biomass, and uses much less solvent and energy than the more typical approach.
The technique can, and already has, created natural ingredients for global customers across a range of industries, including food and beverage, nutrition, supplements, pharmaceuticals and cosmetics.
- [By Matthew Briar]
At first glance, a new set of rules from the Drug Enforcement Agency unveiled in the middle of December looked like it posed a problem for cannabis-newcomer Radient Technologies Inc (CVE:RTI). By assigning a controlled substances code number to ‘marijuana extract,’ simultaneously distinguishing (and acknowledging the differences of marijuana, hemp and their derivatives as Schedule I substances. As the ruling’s language explained, “This code number will allow DEA and DEA-registered entities to track quantities of this material separately from quantities of marihuana. This, in turn, will aid in complying with relevant treaty provisions.”
It presents something of an uncertainty, as it was not clear of the DEA also meant hemp and cannabis extracts when it used the term ‘marijuana extract.’ After all, the Drug Enforcement Agency has thus far done a poor job of distinguishing between hemp and marijuana, but has generally erred on the side of grouping everything as marijuana…. even if it didn’t cause a ‘high,’ and even if it did provide a medical benefit. If that was indeed the case, Radient Technologies may well be a non-starter in its quest to get into the cannabis business.
No need to worry. Though it took weeks to get some much-needed clarification, the DEA has finally explained what it was saying two months ago. Indeed, the new ruling may actually help the medical marijuana — cannabis — along. DEA spokesman Russ Baer said in an e-mail to The Cannabist, “(The rule change) recognizes that there is a potential medical benefit to some of the cannabinoids.”
Some still worry the wording of the law essentially, even if unintentionally, puts cannabinoids (or CBD) under the purveyance of the DEA; it’s currently not. Even so, if nothing else the ruling has the government moving towards clarity, after acknowledging CBD — the healthy version of the cannabis, and not the one that gets you high — has medical value. The next step is clarifying ho
- [By Bryan Murphy]
It’s been a long time in the coming, but there’s no denying the tipping point has been reached — cannabinoids are the foundation for a whole new kind of medicine. And, the work-to-date turning cannabis into pharmaceuticals has been very encouraging.
Problem: While the premise of cannabinoids as drugs has been validated, the science of creating large quantities of pure cannabinoids remains more ineffective than effective. Radient Technologies Inc (CVE:RTI) is about the change that, leveraging a means of extracting a lot of cannabinoid material from a source, and ensuring the highest-level of purity and quality.
Radient Technologies manufactures natural ingredients for global customers across a range of industries, including food and beverage, nutrition, supplements, pharmaceuticals and cosmetics. Using a proprietary, patented technology, Radient’s products are superior in quality and purity while manufactured at a significantly lower cost than other methods thanks to superior yields and efficiency.
To fully appreciate the science Radient has developed, however, one must understand the alternative methods currently employed.
With current approaches to create ingredients from an appropriate source, the material with the target compound or molecule in it is soaked in a solvent, heated, and then over the course of several hours the desired ingredient diffuses into the solvent. After filtration, drying, and other processing, that ingredient is finally isolated and then collected.
It works, but it’s far from ideal. Aside from the fact that this technique doesn’t work very well at large scale, yields are relatively low. Worse, many undesirable components can still be found in the extract, lowering the quality and purity of the ingredient.
Radient Technologies uses an ingredient-extraction process called microwave assisted processing, or “MAP,” for short.
Using its patented MAP process, Radient is able to selectiv
- [By Jim Robertson]
Small cap Radient Technologies (CVE: RTI) is focused on extracting, isolating and purifying food/nutraceutical ingredients (colourings, flavourings, preservatives etc) and pharmaceutical raw materials from its20,000 square foot manufacturing plant in Edmonton, Alberta. The Companyworks with global brands across a range of industries (including Food and Beverage, Nutrition and Supplements, Pharmaceuticals, Personal Care and Cosmetics and Biofuel) andengageswithits clients in three distinct phases:
- [By Ben Levisohn]
FBR’s Thomas Curran and Mark Kelley contend that Halliburton (HAL) and Baker Hughes (BHI) will need General Electric’s (GE) help if their merger–blocked yesterday by the Department of Justice–is to succeed:
Confirming the past week’s media reports, the U.S. Department of Justice (DOJ) announced yesterday, April 6, that it will sue to block the Halliburton-Baker Hughes merger. Based on our initial take, the crux of the DOJ’s objection is that Halliburton’s proposal does not create an adequate replacement for Baker Hughes. In an immediate press release,Halliburton replied that the two companies will “vigorously contest” the DOJ’s case; and, as both stocks rose in an oil price surgefueled group rally, the spread actually narrowed modestly. We suspect the spread’s move from $18.17 (implied gross return of 46.2%) to $16.98 (39.7%) reflected surprise by some thatHalliburton believes it still has a case. Cognizant of the now much lower odds of closing, we still like BHI’s risk/reward here: Should the deal fail, it will benefit from the $3.5B breakup fee, with the ability to fully implement restructuring initiatives that have bee n constrained by the merger agreement ($100M in 4Q15, or 300 bps of margin) and a spreading perception that it is back in play; should the deal succeed, the stock will deliver a 40% return, all else constant, within three to four months…
Any “Hail Mary” solution still likely relies on GE Oil & Gas (GE). Based on the trail of evidence to date, we presume the “prospective buyer” that Halliburton has had “lengthy discussions” with is General Electric. We have long held that, should the deal succeed, it will be because General Electric agrees to buy most, if not all, of the assets; we believe the DOJ’s complaint reinforces this view.
Shares of Halliburton have dropped 1.2% to $36
- [By Tony Daltorio]
The biggest oilfield service companies should get a big lift from the boom, Moors said. That includes Schlumberger Ltd. (NYSE: SLB), Halliburton Co. (NYSE: HAL), Weatherford International Ltd. (NYSE: WFT), and Baker Hughes Inc. (NYSE: BHI).
- [By Wayne Duggan]
Trump is particularly enthusiastic about shale oil & gas and clean coal, which is good news for stocks such as Chesapeake Energy Corporation (NYSE: CHK), Halliburton Company (NYSE: HAL) and CONSOL Energy Inc. (NYSE: CNX).